Lakewood, CO, United States of America

Gambro Bct, Inc.

Calculating rank
USPTO Granted Patents = 8

Forward Citations = 194

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Geert Van Waeg (2 out of 18 patents)

silverMedal Peter Pihlstedt (2 out of 14 patents)

bronzeMedal Joseph A Scibona (2 out of 11 patents)

4.  Brian M Holmes (2 out of 50 patents)

5.  Shannon Durkee (2 out of 2 patents)

6.  Linda A Taylor (1 out of 13 patents)

7.  Glen Delbert Antwiler (1 out of 28 patents)

8.  Johan-Petter Hagström (1 out of 7 patents)

9.  Per-Olov Jan Lundberg (1 out of 5 patents)

10.  Niclas Högberg (1 out of 6 patents)

11.  Emanuel Hällgren (1 out of 6 patents)

12.  Peter Nordgren (1 out of 16 patents)

13.  Scott Butzke (1 out of 6 patents)

14.  Muriel Keller (1 out of 5 patents)

15.  Timothy M Gordon (1 out of 10 patents)


8 patents:

Company Overview
Gambro Bct, Inc. is a leading global medical technology company that specializes in developing products for renal care. With a focus on innovation and quality, Gambro Bct, Inc. provides a range of solutions for dialysis, blood purification, and other related therapies. Their products are designed to improve the lives of patients with kidney disease and other medical conditions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

8 Patents

#20 in Lakewood, CO

#775 in Colorado

#36,017 in US

Lakewood, CO (US)
Lakewood, CO, United States of America
Forward Citations = 194

19 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gambro Bct, Inc.. Retrieved from https://idiyas.com/company/gambro-bct

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…